Drug may ease emotional pain after pregnancy loss procedure
NCT ID NCT07537894
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests whether giving a medicine called dexmedetomidine during a second-trimester dilation and evacuation (D&E) can lower the chances of severe grief and post-traumatic stress after the procedure. About 100 people having a D&E in the operating room will be randomly assigned to receive the drug or a placebo. The goal is to see if calming the body's stress response during the procedure can improve emotional recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Health Care
Palo Alto, California, 94062, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a climate-smart pregnancy care program prevent stillbirths in a fast-growing city?
- A new model aims to predict stillbirth before it happens
- Placental clues from a past pregnancy may guide treatment to prevent future complications
- A single virtual talk after a traumatic birth may ease lasting emotional distress
- Can a common drug make abortion safer? new trial aims to find out
- New study seeks to uncover reasons behind late abortions